 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Eton Pharmaceuticals Inc. (ETON)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2018-11-15 Purchase | 2018-11-15 7:06 pm | Eton Pharmaceuticals Inc. | ETON | BAUM MARK L Director | 10,000 | $6 | $60,000 | 10,000 (Indirect Direct) | View |
| 2018-11-15 Purchase | 2018-11-15 7:07 pm | Eton Pharmaceuticals Inc. | ETON | Troutman William Wilson CFO | 5,000 | $6 | $30,000 | 5,000 (Direct) | View |
| 2018-11-15 Purchase | 2018-11-15 7:10 pm | Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director | 5,000 | $6 | $30,000 | 59,745 (Direct) | View |
| 2018-11-15 Purchase | 2018-11-15 7:13 pm | Eton Pharmaceuticals Inc. | ETON | MAIER PAUL V Director | 5,000 | $6 | $30,000 | 59,745 (Direct) | View |
| 2018-11-15 Purchase | 2018-11-15 7:23 pm | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN CEO | 10,000 | $6 | $60,000 | 1,010,000 (Indirect Direct) | View |
| 2018-11-15 Purchase | 2018-11-15 7:24 pm | Eton Pharmaceuticals Inc. | ETON | CASAMENTO CHARLES J Director | 5,000 | $6 | $30,000 | 68,420 (Direct) | View |
| 2019-05-20 Purchase | 2019-05-22 4:25 pm | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN CEO | 10,000 | $7.9326 | $79,326 | 1,020,000 (Indirect Direct) | View |
| 2019-08-09 Purchase | 2019-08-12 4:17 pm | Eton Pharmaceuticals Inc. | ETON | CASAMENTO CHARLES J Director | 3,500 | $6.1057 | $21,370 | 71,920 (Direct) | View |
| 2019-08-13 Purchase | 2019-08-13 4:04 pm | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN CEO | 5,000 | $6.15 | $30,750 | 1,025,000 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2018-11-15 Conversion | 2018-11-15 7:23 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN CEO | 24,940 | $0 | 1,010,000 (Indirect) | View |
| 2018-11-15 Conversion | 2018-11-15 7:23 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN CEO | 23,000 | $0 | 1,010,000 (Indirect) | View |
| 2018-11-15 Conversion | 2018-11-15 7:24 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | CASAMENTO CHARLES J Director | 8,675 | $0 | 68,420 (Direct) | View |
| 2018-11-15 Conversion | 2018-11-15 7:24 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | CASAMENTO CHARLES J Director | 8,000 | $0 | 68,420 (Direct) | View |
| 2019-02-20 Option Award | 2019-03-08 4:30 pm | N/A 2029-02-19 | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN CEO | 250,000 | $7.31 | 250,000 (Direct) | View |
| 2019-02-20 Option Award | 2019-03-08 4:31 pm | N/A 2029-02-19 | Eton Pharmaceuticals Inc. | ETON | Troutman William Wilson CFO | 95,000 | $7.31 | 95,000 (Direct) | View |
| 2019-02-20 Option Award | 2019-03-08 4:32 pm | N/A 2029-02-19 | Eton Pharmaceuticals Inc. | ETON | BAUM MARK L Director | 12,500 | $7.31 | 12,500 (Direct) | View |
| 2019-02-20 Option Award | 2019-03-08 4:33 pm | N/A 2029-02-19 | Eton Pharmaceuticals Inc. | ETON | CASAMENTO CHARLES J Director | 12,500 | $7.31 | 12,500 (Direct) | View |
| 2019-02-20 Option Award | 2019-03-08 4:34 pm | N/A 2029-02-19 | Eton Pharmaceuticals Inc. | ETON | MAIER PAUL V Director | 12,500 | $7.31 | 12,500 (Direct) | View |
| 2019-02-20 Option Award | 2019-03-08 4:35 pm | N/A 2029-02-19 | Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director | 12,500 | $7.31 | 12,500 (Direct) | View |
| 2020-03-12 Option Award | 2020-03-16 4:52 pm | N/A 2030-03-11 | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN CEO | 490,000 | $3.58 | 490,000 (Direct) | View |
| 2020-03-12 Option Award | 2020-03-16 4:52 pm | N/A 2030-03-11 | Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director | 27,400 | $3.58 | 27,400 (Direct) | View |
| 2020-03-12 Option Award | 2020-03-16 4:54 pm | N/A 2030-03-11 | Eton Pharmaceuticals Inc. | ETON | MAIER PAUL V Director | 27,400 | $3.58 | 27,400 (Direct) | View |
| 2020-03-12 Option Award | 2020-03-16 4:56 pm | N/A 2030-03-11 | Eton Pharmaceuticals Inc. | ETON | CASAMENTO CHARLES J Director | 27,400 | $3.58 | 27,400 (Direct) | View |
| 2020-03-12 Option Award | 2020-03-16 4:56 pm | N/A 2030-03-11 | Eton Pharmaceuticals Inc. | ETON | Troutman William Wilson CFO | 186,200 | $3.58 | 186,200 (Direct) | View |
| 2020-03-12 Option Award | 2020-03-16 4:58 pm | N/A 2030-03-11 | Eton Pharmaceuticals Inc. | ETON | BAUM MARK L Director | 27,400 | $3.58 | 27,400 (Direct) | View |